• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Consumer Defensive·BARN.SW
Share

Barry Callebaut AG Stocks

CHF 1121Last Updated 30.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CHF 7.79B

CHF 1121
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Barry Callebaut AG, operating with its subsidiaries, is a leading global manufacturer and distributor of an extensive array of cocoa and chocolate products. The company's diverse offerings include various chocolate compounds, chips, and chunks, alongside raw cocoa, cacao fruit derivatives, and a selection of fillings, coatings, nuts, decorative inclusions, and food colorants, including custom personalization sheets. Beyond these, it supplies cocoa powder, a range of chocolate drinks, cappuccinos, dessert beverages, dairy and non-dairy options, tea, and coffee. These items are sold under prominent brands such as Cacao Barry, Callebaut, Carma, Mona Lisa, Van Houten Professional, Bensdorp, Cabosse Naturals, D'Orsogna Dolciaria, IBC, and La Morella Nuts. Additionally, Barry Callebaut provides centralized treasury and management services, as well as conference and training programs. Its broad customer base encompasses food manufacturers, artisanal producers, and professional chocolate users, including chocolatiers, pastry chefs, bakers, hotels, restaurants, and caterers, along with specialized products for vending machines. The company has a significant operational footprint, primarily in the United States, Germany, the United Kingdom, Belgium, France, Mexico, Brazil, Poland, and Switzerland, extending throughout the rest of Europe, the Americas, and the Asia Pacific region. Founded in 1994, Barry Callebaut AG is headquartered in Zürich, Switzerland.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of BARN.SW is 1277 and suggests 12.2% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommenda

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.07.2026 20:33

"A Key Source of Value and Risk": Wall Street's Top Tech Optimist Assesses SpaceX

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

01.07.2026 18:59

Meta will launch a cloud infrastructure business. It will compete with Google and Nebius

01.07.2026 18:47

BlackRock is betting on scarce resources in AI supply chains. How should you build your portfolio?

01.07.2026 18:39

Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026